KRISPY KREME INC (DNUT) Fundamental Analysis & Valuation

NASDAQ:DNUT • US50101L1061

Current stock price

3.665 USD
-0.11 (-3.04%)
Last:

This DNUT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DNUT Profitability Analysis

1.1 Basic Checks

  • In the past year DNUT has reported negative net income.
  • In the past year DNUT had a positive cash flow from operations.
  • In the past 5 years DNUT reported 4 times negative net income.
  • DNUT had a positive operating cash flow in each of the past 5 years.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -20.06%, DNUT is doing worse than 92.86% of the companies in the same industry.
  • The Return On Equity of DNUT (-80.00%) is worse than 73.02% of its industry peers.
Industry RankSector Rank
ROA -20.06%
ROE -80%
ROIC N/A
ROA(3y)-7.04%
ROA(5y)-4.48%
ROE(3y)-27.65%
ROE(5y)-17.26%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • DNUT has a worse Gross Margin (28.98%) than 78.57% of its industry peers.
  • In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for DNUT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. DNUT Health Analysis

2.1 Basic Checks

  • DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DNUT has more shares outstanding
  • The number of shares outstanding for DNUT has been increased compared to 5 years ago.
  • Compared to 1 year ago, DNUT has a worse debt to assets ratio.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.16, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of DNUT (0.16) is worse than 86.51% of its industry peers.
  • DNUT has a Debt/Equity ratio of 1.40. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of DNUT (1.40) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACC7.12%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.38 indicates that DNUT may have some problems paying its short term obligations.
  • The Current ratio of DNUT (0.38) is worse than 88.10% of its industry peers.
  • A Quick Ratio of 0.32 indicates that DNUT may have some problems paying its short term obligations.
  • DNUT's Quick ratio of 0.32 is on the low side compared to the rest of the industry. DNUT is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.32
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DNUT Growth Analysis

3.1 Past

  • DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.33%.
  • DNUT shows a decrease in Revenue. In the last year, the revenue decreased by -8.57%.
  • The Revenue has been growing slightly by 6.30% on average over the past years.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y-0.16%
Revenue growth 5Y6.3%
Sales Q2Q%-2.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.42% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.08% on average over the next years.
EPS Next Y56.4%
EPS Next 2Y27.98%
EPS Next 3Y2.98%
EPS Next 5Y12.42%
Revenue Next Year-1.35%
Revenue Next 2Y1.09%
Revenue Next 3Y3.69%
Revenue Next 5Y7.08%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. DNUT Valuation Analysis

4.1 Price/Earnings Ratio

  • DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DNUT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

  • DNUT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DNUT is more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.02
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.98%
EPS Next 3Y2.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. DNUT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.66%, DNUT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.05, DNUT pays a better dividend. On top of this DNUT pays more dividend than 92.06% of the companies listed in the same industry.
  • DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.66%

5.2 History

  • DNUT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • The earnings of DNUT are negative and hence is the payout ratio. DNUT will probably not be able to sustain this dividend level.
DP-2.29%
EPS Next 2Y27.98%
EPS Next 3Y2.98%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

DNUT Fundamentals: All Metrics, Ratios and Statistics

KRISPY KREME INC

NASDAQ:DNUT (4/29/2026, 10:13:05 AM)

3.665

-0.11 (-3.04%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Industry Strength28.57
Industry Growth43.48
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners43.46%
Inst Owner Change-0.01%
Ins Owners3.22%
Ins Owner Change-0.06%
Market Cap631.11M
Revenue(TTM)1.52B
Net Income(TTM)-520.07M
Analysts53.85
Price Target4.76 (29.88%)
Short Float %22.13%
Short Ratio7.41
Dividend
Industry RankSector Rank
Dividend Yield 3.66%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-2.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.6%
Min EPS beat(2)118.57%
Max EPS beat(2)184.63%
EPS beat(4)2
Avg EPS beat(4)-12.9%
Min EPS beat(4)-353.46%
Max EPS beat(4)184.63%
EPS beat(8)3
Avg EPS beat(8)-41%
EPS beat(12)5
Avg EPS beat(12)-31.81%
EPS beat(16)7
Avg EPS beat(16)-25.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.28%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)-0.53%
Revenue beat(8)0
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-1.67%
Revenue beat(16)4
Avg Revenue beat(16)-1.42%
PT rev (1m)7.63%
PT rev (3m)6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)24.51%
EPS NY rev (1m)36.03%
EPS NY rev (3m)61.6%
Revenue NQ rev (1m)1.22%
Revenue NQ rev (3m)-5.22%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF 18.6
P/B 0.97
P/tB N/A
EV/EBITDA 17.02
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.2
OCFY5.38%
SpS8.84
BVpS3.78
TBVpS-4.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -20.06%
ROE -80%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.98%
FCFM N/A
ROA(3y)-7.04%
ROA(5y)-4.48%
ROE(3y)-27.65%
ROE(5y)-17.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Debt/EBITDA 9.78
Cap/Depr 71.44%
Cap/Sales 6.43%
Interest Coverage N/A
Cash Conversion 36.4%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.32
Altman-Z 0.16
F-Score5
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)86.1%
Cap/Depr(5y)95.44%
Cap/Sales(3y)6.96%
Cap/Sales(5y)7.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y56.4%
EPS Next 2Y27.98%
EPS Next 3Y2.98%
EPS Next 5Y12.42%
Revenue 1Y (TTM)-8.57%
Revenue growth 3Y-0.16%
Revenue growth 5Y6.3%
Sales Q2Q%-2.88%
Revenue Next Year-1.35%
Revenue Next 2Y1.09%
Revenue Next 3Y3.69%
Revenue Next 5Y7.08%
EBIT growth 1Y-248.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.69%
EBIT Next 3Y38.11%
EBIT Next 5Y23.83%
FCF growth 1Y14.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.98%
OCF growth 3Y-37.63%
OCF growth 5Y3.4%

KRISPY KREME INC / DNUT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


What is the valuation status of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


What is the profitability of DNUT stock?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


Can you provide the financial health for DNUT stock?

The financial health rating of KRISPY KREME INC (DNUT) is 0 / 10.


Is the dividend of KRISPY KREME INC sustainable?

The dividend rating of KRISPY KREME INC (DNUT) is 4 / 10 and the dividend payout ratio is -2.29%.